Literature DB >> 12109661

Long-term Helicobacter pylori infection and the development of atrophic gastritis and gastric cancer in Japan.

Shin'ichi Takahashi1.   

Abstract

The incidence of gastric cancer and the prevalence of Helicobacter pylori are high in Japan, so it is an important issue whether long-term H. pylori infection leads to chronic atrophic gastritis, considered one of the precursors of gastric cancer. We have reported that the grade of atrophy was higher in H. pylori-positive subjects than in H. pylori-negative subjects. It has also been reported that the atrophy of gastric mucosa increased in H. pylori-infected monkeys compared with control monkeys in a 5-year follow-up study. Most H. pylori infections occur in children, and atrophy of the gastric mucosa progresses during aging. Long-term data show that H. pylori infection can lead to gastric atrophy and may play an important role in the development of gastric cancer. Interestingly, there was no difference in the prevalence of H. pylori between patients with chronic gastritis and gastric cancer in Japan, but the prevalence of H. pylori in young Japanese gastric cancer patients was significantly higher than in the control group. These data clearly show that H. pylori infection is one of the risk factors of gastric cancer in young Japanese people, There is no answer to whether curing H. pylori infection can reverse the atrophy of the gastric mucosa and decrease the risk of gastric cancer development. To clarify this issue, an intervention study must be done. A large clinical trial called the Japanese Intervention Trial of H. pylori is in progress.

Entities:  

Mesh:

Year:  2002        PMID: 12109661     DOI: 10.1007/bf02990095

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  19 in total

1.  Induction of gastric ulcer and intestinal metaplasia in mongolian gerbils infected with Helicobacter pylori.

Authors:  F Hirayama; S Takagi; H Kusuhara; E Iwao; Y Yokoyama; Y Ikeda
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

2.  Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated.

Authors:  T Ohkusa; K Fujiki; I Takashimizu; J Kumagai; T Tanizawa; Y Eishi; T Yokoyama; M Watanabe
Journal:  Ann Intern Med       Date:  2001-03-06       Impact factor: 25.391

3.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

4.  Serum pepsinogens as a screening test of extensive chronic gastritis.

Authors:  K Miki; M Ichinose; A Shimizu; S C Huang; H Oka; C Furihata; T Matsushima; K Takahashi
Journal:  Gastroenterol Jpn       Date:  1987-04

5.  Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population.

Authors:  M Asaka; T Kimura; M Kudo; H Takeda; S Mitani; T Miyazaki; K Miki; D Y Graham
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

6.  Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality.

Authors:  S Tsugane; M Kabuto; H Imai; F Gey; Y Tei; T Hanaoka; K Sugano; S Watanabe
Journal:  Cancer Causes Control       Date:  1993-07       Impact factor: 2.506

7.  The influence of Helicobacter pylori infection on the progression of gastric mucosal atrophy and occurrence of gastric cancer.

Authors:  N Sakaki; K Momma; N Egawa; Y Yamada; T Kan; J Ishiwata
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-08       Impact factor: 2.566

8.  Helicobacter pylori infection is the major risk factor for atrophic gastritis.

Authors:  H Kawaguchi; K Haruma; K Komoto; M Yoshihara; K Sumii; G Kajiyama
Journal:  Am J Gastroenterol       Date:  1996-05       Impact factor: 10.864

9.  Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis.

Authors:  K Satoh; K Kimura; Y Taniguchi; Y Yoshida; K Kihira; T Takimoto; H Kawata; K Saifuku; K Ido; T Takemoto; Y Ota; M Tada; M Karita; N Sakaki; Y Hoshihara
Journal:  Am J Gastroenterol       Date:  1996-05       Impact factor: 10.864

10.  Long-term effect of Helicobacter pylori infection on serum pepsinogens.

Authors:  S Kikuchi; M Kurosawa; T Sakiyama; H Tenjin; K Miki; O Wada; Y Inaba
Journal:  Jpn J Cancer Res       Date:  2000-05
View more
  11 in total

1.  Gastric carcinoid in a patient infected with Helicobacter pylori: a new entity?

Authors:  Pantelis Antonodimitrakis; Apostolos Tsolakis; Staffan Welin; Gordana Kozlovacki; Kjell Oberg; Dan Granberg
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

2.  Construction of a recombinant attenuated Salmonella typhimurium DNA vaccine carrying Helicobacter pylori hpaA.

Authors:  Can Xu; Zhao-Shen Li; Yi-Qi Du; Zhen-Xing Tu; Yan-Fang Gong; Jing Jin; Hong-Yu Wu; Guo-Ming Xu
Journal:  World J Gastroenterol       Date:  2005-01-07       Impact factor: 5.742

3.  Construction of recombinant attenuated Salmonella typhimurium DNA vaccine expressing H pylori ureB and IL-2.

Authors:  Can Xu; Zhao-Shen Li; Yi-Qi Du; Yan-Fang Gong; Hua Yang; Bo Sun; Jing Jin
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

4.  Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years.

Authors:  Gotaro Masuda; Akira Tokunaga; Takashi Shirakawa; Akiyoshi Togashi; Teruo Kiyama; Shunji Kato; Norio Matsukura; Hideki Bou; Masanori Watanabe; Takashi Tajiri
Journal:  Gastric Cancer       Date:  2007-06-25       Impact factor: 7.370

5.  Old and new TNM in carcinoma of the gastric antrum: analysis of our personal experience.

Authors:  Paolo Del Rio; Paolo Dell'Abate; Paolo Soliani; Maria Francesca Arcuri; Sara Tacci; Stefanie Ziegler; Mario Sianesi
Journal:  J Gastrointest Surg       Date:  2003-11       Impact factor: 3.452

6.  Prominent role of gamma-glutamyl-transpeptidase on the growth of Helicobacter pylori.

Authors:  Min Gong; Bow Ho
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

7.  Reduction in serum pepsinogen I after Roux-en-Y gastric bypass.

Authors:  Magnus Sundbom; Erik Mårdh; Sven Mårdh; Margareta Ohrvall; Sven Gustavsson
Journal:  J Gastrointest Surg       Date:  2003 May-Jun       Impact factor: 3.452

8.  Dietary prevention of Helicobacter pylori-associated gastric cancer with kimchi.

Authors:  Migyeong Jeong; Jong-Min Park; Young-Min Han; Kun Young Park; Don Haeng Lee; Joon-Hwan Yoo; Joo Young Cho; Ki-Baik Hahm
Journal:  Oncotarget       Date:  2015-10-06

Review 9.  Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening.

Authors:  Xian-Zhe Chen; Cheng-Zhi Huang; Wei-Xian Hu; Ying Liu; Xue-Qing Yao
Journal:  Chin Med J (Engl)       Date:  2018-05-20       Impact factor: 2.628

10.  Gastric neuroendocrine tumor with Helicobacter pylori-associated chronic gastritis.

Authors:  Giovanni Serio; Armando Dell'Anna; Anna Debenedittis; Elisa Stasi; Maria Arcangela Cascarano
Journal:  Int J Surg Case Rep       Date:  2020-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.